Literature DB >> 16299809

Age dependent phosphorylation and deregulation of p53 in human vestibular schwannomas.

Antony H P P Dayalan1, Mathivanan Jothi, Rohini Keshava, Remy Thomas, Mohan L Gope, Subbakrishna K Doddaballapur, Sampath Somanna, Shanti S Praharaj, Chandramouli B Ashwathnarayanarao, Rajalakshmi Gope.   

Abstract

Tumor-specific alterations at the p53 gene locus in 30 human vestibular schwannomas (VS) comprising 10 confirmed NF2 cases and 20 sporadic cases were analyzed. We found loss of heterozygosity (LOH) at the first intron of the p53 gene locus in 54% of the informative cases. This is the first report showing LOH at the p53 gene locus in a significant number of human VS and both sporadic and NF2 cases show the LOH event. Increased levels of normal size p53 mRNA and p53 protein were found in all the tumors analyzed. Thus p53 appears to be deregulated in all the tumors suggesting that p53 alterations may be associated with tumor progression in VS. There was a negative significant correlation of patients' age and percentage of Ser 392 phosphorylated p53 protein. The tumor samples obtained from younger patients of 35 yr and below showed higher percentage of Ser 392 phosphorylated p53 protein compared to the tumors of older patients. The increased percentage of Ser 392 phosphorylated p53 protein indicates that it could be involved in the acceleration of tumor growth in the younger patients. Our results suggest that age dependent phosphorylation of p53 protein and deregulation of p53 gene has a role in the development of human vestibular schwannomas. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16299809     DOI: 10.1002/mc.20150

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

1.  The role of NF2 gene mutations and pathogenesis-related proteins in sporadic vestibular schwannomas in young individuals.

Authors:  Hongsai Chen; Xiaoman Zhang; Zhihua Zhang; Tao Yang; Zhaoyan Wang; Hao Wu
Journal:  Mol Cell Biochem       Date:  2014-03-12       Impact factor: 3.396

2.  Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.

Authors:  Sonam Dilwali; Martijn C Briët; Shyan-Yuan Kao; Takeshi Fujita; Lukas D Landegger; Michael P Platt; Konstantina M Stankovic
Journal:  Mol Oncol       Date:  2015-03-31       Impact factor: 6.603

3.  Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas.

Authors:  Hongsai Chen; He Huang; Jingjing Zhao; Zhigang Wang; Mengling Chang; Lu Xue; Weidong Zhu; Yongchuan Chai; Gen Li; Zhaoyan Wang; Hao Wu
Journal:  J Neurooncol       Date:  2019-05-02       Impact factor: 4.130

4.  Altered structure and deregulated expression of the tumor suppressor gene retinoblastoma (RB1) in human brain tumors.

Authors:  J Mathivanan; K Rohini; Mohan L Gope; B Anandh; Rajalakshmi Gope
Journal:  Mol Cell Biochem       Date:  2007-02-23       Impact factor: 3.396

5.  P14ARF deficiency and its correlation with overexpression of p53/MDM2 in sporadic vestibular schwannomas.

Authors:  Ying Chen; Zhao-Yan Wang; Hao Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-26       Impact factor: 2.503

6.  Loss of heterozygosity of the p53 gene and deregulated expression of its mRNA and protein in human brain tumors.

Authors:  K Rohini; J Mathivanan; P D Antony Herold Prabhu; D K Subbakrishna; M L Gope; B A Chandramouli; S Sampath; B Anandh; R Gope
Journal:  Mol Cell Biochem       Date:  2006-12-16       Impact factor: 3.842

7.  Novel age-dependent targets in vestibular schwannomas.

Authors:  Amos Toren; Juergen K Reichardt; Ali Andalibi; Nancy Ya-Hsuan Hsu; Joni Doherty; William Slattery; Ruty Mehrian-Shai
Journal:  Hum Genomics       Date:  2014-06-30       Impact factor: 4.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.